RT Journal Article SR Electronic T1 Identification of SARS-CoV-2 RNA in Healthcare Heating, Ventilation, and Air Conditioning Units JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.06.26.20141085 DO 10.1101/2020.06.26.20141085 A1 Patrick F. Horve A1 Leslie Dietz A1 Mark Fretz A1 David A. Constant A1 Andrew Wilkes A1 John M. Townes A1 Robert G. Martindale A1 William B. Messer A1 Kevin G. Van Den Wymelenberg YR 2020 UL http://medrxiv.org/content/early/2020/06/28/2020.06.26.20141085.abstract AB Available information on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) transmission by small particle aerosols continues to evolve rapidly. To assess the potential role of heating, ventilation, and air conditioning (HVAC) systems in airborne viral transmission, this study sought to determine the viral presence, if any, on air handling units in a healthcare setting where Coronavirus Disease 2019 (COVID-19) patients were being treated. The presence of SARS-CoV-2 RNA was detected in approximately 25% of samples taken from nine different locations in multiple air handlers. While samples were not evaluated for viral infectivity, the presence of viral RNA in air handlers raises the possibility that viral particles can enter and travel within the air handling system of a hospital, from room return air through high efficiency MERV-15 filters and into supply air ducts. Although no known transmission events were determined to be associated with these specimens, the findings suggest the potential for HVAC systems to facilitate transmission by environmental contamination via shared air volumes with locations remote from areas where infected persons reside. More work is needed to further evaluate the risk of SARS-CoV-2 transmission via HVAC systems and to verify effectiveness of building operations mitigation strategies for the protection of building occupants. These results are important within and outside of healthcare settings and may present a matter of some urgency for building operators of facilities that are not equipped with high-efficiency filtration.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research benefited from the University of Oregon and Oregon Health and Science University seed research funds and the Oregon Health and Science Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Environmental sampling does not require Institutional Review Board (IRB) approval; however, the project was reviewed by the OHSU IRB and an IRB Exemption was granted for this work.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data available upon request.